Hyalex Orthopaedics
PrivateLast Round
Series B
Oct 2, 2024
Est. Valuation
$68.9M
Total Funding Raised
$47.9M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Hyalex Orthopaedics operates in Healthcare & Life Sciences and is based in Lexington, Massachusetts. Its latest recorded funding round was a Series B round in October 2024.
Hyalex Orthopaedics is a medical technology company that develops a biomimetic synthetic cartilage platform for the treatment of diseased and damaged joints.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hyalex Orthopaedics Comparables
Compare Hyalex Orthopaedics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sparta Biomedical | 83% | |
| BioPoly LLC | 83% | |
| Nanochon | 81% |
For institutional investors. Book with your work email.
Hyalex Orthopaedics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 2, 2024 | ||||
| Series A Extension | Mar 28, 2019 | ||||
| Series A | May 31, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Hyalex Orthopaedics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Osage University Partners | Series A Extension, Series A |
| Canaan Partners | Series A Extension, Series A |
| DSM Venturing | Series A, Series A Extension |
| Johnson & Johnson Innovation – JJDC | Series A Extension, Series A |
| Johnson & Johnson Innovation - JJDC, Inc. | Series A, Series A Extension |
| Treo Ventures | Series A, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 34% MoM, from 2.2K to 3K.
- Oct 14, 2025
Will present clinical study data at the ICRS Congress 2025.
For institutional investors. Book with your work email.
Hyalex Orthopaedics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Hyalex Orthopaedics's valuation, stock price, and market status.
Is Hyalex Orthopaedics a public or private company?
Hyalex Orthopaedics is a private company.
What is the current stock price of Hyalex Orthopaedics?
Hyalex Orthopaedics is a private company, so its shares have no public market price. Caplight tracks Hyalex Orthopaedics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Hyalex Orthopaedics worth (valuation)?
Hyalex Orthopaedics's valuation is estimated at $68.9M based on funding round data.
Can I buy Hyalex Orthopaedics stock?
Hyalex Orthopaedics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Hyalex Orthopaedics's last funding round?
Hyalex Orthopaedics's most recent funding round was Series B on October 2, 2024.
Who are the main investors in Hyalex Orthopaedics?
Key investors in Hyalex Orthopaedics include Canaan Partners, Treo Ventures.
Will Hyalex Orthopaedics IPO soon?
No public IPO plans have been announced for Hyalex Orthopaedics.
How can I track Hyalex Orthopaedics secondary market activity?
Caplight tracks bids, offers, and trades in Hyalex Orthopaedics's shares on secondary markets.